-- 加拿大议会预算办公室（PBO）周四表示，已审查了加拿大联邦政府2026-27财年的支出计划和主要预算估算，该计划和估算支持一项拨款法案，该法案寻求议员批准2304亿加元的预算授权。 PBO指出，议会已通过其他立法为2026-27财年计划支出的大部分（2724亿加元）提供了立法授权。 其中，PBO指出，加拿大医疗拨款将在2026-27财年增加27亿加元（5%），达到574亿加元；联邦政府在老年人福利方面的支出将在2026-27财年增加57亿加元（6.9%），达到888亿加元。然而，议会预算办公室（PBO）表示，在提交主要预算估算后，政府发布了《2026年春季经济展望》，该展望预测2026-27财年老年人福利支出将达到893亿澳元（增加69亿澳元，增幅7.6%）。 其他亮点包括：2026-27财年主要预算估算中，预计用于偿还公共债务的法定授权支出为537亿澳元，较2025-26财年迄今为止的预算估算增加了47亿澳元（9.5%），其中包括486亿澳元用于未到期债务利息，以及51亿澳元用于其他利息支出。 议会预算办公室指出，主要预算估算中包含147亿澳元用于2025年预算措施的资金。此外，与重建、重新武装和重新投资加拿大武装部队相关的举措占 2025 年预算拟议支出的 71.1%，其中包括向国防部 (DND) 拨款 90 亿加元，向加拿大通信安全机构 (CES) 拨款 6.753 亿加元。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO